Income Statement Smith & Nephew Plc
Stocks
SN.
GB0009223206
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,151.00 GBX | +3.32% |
|
+2.22% | -7.06% |
| 10:33am | WINNERS & LOSERS: ICG assets rise; miners track lower gold prices | AN |
| 07-14 | Soft US inflation helps FTSE shake off oil surge | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 5.21B | 5.22B | 5.55B | 5.81B | 6.16B | |||||
Total Revenues | 5.21B | 5.22B | 5.55B | 5.81B | 6.16B | |||||
Cost of Goods Sold, Total | 1.51B | 1.52B | 1.66B | 1.73B | 1.96B | |||||
Gross Profit | 3.7B | 3.7B | 3.89B | 4.08B | 4.21B | |||||
Selling General & Admin Expenses, Total | 2.64B | 2.71B | 2.83B | 2.9B | 3.04B | |||||
R&D Expenses | 349M | 335M | 320M | 289M | 294M | |||||
Other Operating Expenses, Total | 2.99B | 3.04B | 3.15B | 3.19B | 3.33B | |||||
Operating Income | 712M | 653M | 738M | 886M | 877M | |||||
Interest Expense, Total | -80M | -80M | -132M | -145M | -140M | |||||
Interest And Investment Income | 6M | 14M | 34M | 24M | 28M | |||||
Net Interest Expenses | -74M | -66M | -98M | -121M | -112M | |||||
Income (Loss) On Equity Invest. | 9M | -141M | -30M | -10M | 113M | |||||
Currency Exchange Gains (Loss) | - | - | - | - | - | |||||
Other Non Operating Income (Expenses) | -6M | 1M | - | -24M | -10M | |||||
EBT, Excl. Unusual Items | 641M | 447M | 610M | 731M | 868M | |||||
Restructuring Charges | -113M | -167M | -220M | -123M | -47M | |||||
Merger & Related Restructuring Charges | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | 75M | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | -2M | -39M | -37M | -16M | -10M | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | -8M | -7M | -6M | - | - | |||||
Other Unusual Items | -7M | 1M | -57M | -94M | -32M | |||||
EBT, Incl. Unusual Items | 586M | 235M | 290M | 498M | 779M | |||||
Income Tax Expense | 62M | 12M | 27M | 86M | 154M | |||||
Earnings From Continuing Operations | 524M | 223M | 263M | 412M | 625M | |||||
Net Income to Company | 524M | 223M | 263M | 412M | 625M | |||||
Net Income - (IS) | 524M | 223M | 263M | 412M | 625M | |||||
Net Income to Common Incl Extra Items | 524M | 223M | 263M | 412M | 625M | |||||
Net Income to Common Excl. Extra Items | 524M | 223M | 263M | 412M | 625M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.6 | 0.26 | 0.3 | 0.47 | 0.72 | |||||
Basic EPS - Continuing Operations | 0.6 | 0.26 | 0.3 | 0.47 | 0.72 | |||||
Basic Weighted Average Shares Outstanding | 877M | 872M | 871M | 873M | 867M | |||||
Net EPS - Diluted | 0.6 | 0.26 | 0.3 | 0.47 | 0.72 | |||||
Diluted EPS - Continuing Operations | 0.6 | 0.26 | 0.3 | 0.47 | 0.72 | |||||
Diluted Weighted Average Shares Outstanding | 878M | 873M | 873M | 876M | 873M | |||||
Normalized Basic EPS | 0.46 | 0.32 | 0.44 | 0.52 | 0.63 | |||||
Normalized Diluted EPS | 0.46 | 0.32 | 0.44 | 0.52 | 0.62 | |||||
Dividend Per Share | 0.38 | 0.38 | 0.38 | 0.38 | 0.39 | |||||
Payout Ratio | 62.79 | 146.64 | 124.33 | 79.37 | 52.8 | |||||
American Depositary Receipts Ratio (ADR) | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.18B | 1.1B | 1.17B | 1.34B | 1.34B | |||||
EBITA | 907M | 839M | 921M | 1.06B | 1.05B | |||||
EBIT | 712M | 653M | 738M | 886M | 877M | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 10.58 | 5.11 | 9.31 | 17.27 | 19.77 | |||||
Total Current Taxes | 107M | 111M | 135M | 158M | 129M | |||||
Total Deferred Taxes | -45M | -99M | -108M | -72M | 25M | |||||
Normalized Net Income | 401M | 279M | 381M | 457M | 542M | |||||
Interest on Long-Term Debt | 28M | 33M | 54M | 97M | 112M | |||||
Non-Cash Pension Expense | 4M | 2M | 5M | -1M | 6M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 81M | 92M | 88M | 84M | 91M | |||||
Research And Development Expense From Footnotes | 397M | 396M | 385M | 343M | 346M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 41M | 40M | 39M | 40M | 43M | |||||
Total Stock-Based Compensation | 41M | 40M | 39M | 40M | 43M |
- Stock Market
- Stocks
- SN. Stock
- Financials Smith & Nephew Plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















